title: Ripe for scrutiny. In wake of probes, PBMs may draw extra attention.
authors.forename: Tony
authors.initials: T
authors.lastname: Fong
mesh_terms: D000368:Aged; D014487:Centers for Medicare and Medicaid Services, U.S.; D004345:Drug Industry; D005569:Formularies as Topic; D005607:Fraud / Q000331:legislation & jurisprudence; D006801:Humans; D007343:Insurance Carriers / Q000331:legislation & jurisprudence*; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence*; D006278:Medicare / Q000458:organization & administration*; D014481:United States